C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
03/1992
03/18/1992	EP0475623A1 Genetic mechanisms of tumor supression
03/18/1992	EP0475394A2 Rat C-type natriuretic peptide cDNA and precursor protein
03/18/1992	EP0475354A2 Sialysation of glycoproteins by genetic technology
03/18/1992	EP0475311A1 Process for removing proteins originating from Escherichia coli
03/18/1992	EP0474979A1 Heparin binding neurotrophic factor gene sequence
03/18/1992	EP0474965A2 DNA encoding acylamino acid racemase and its use
03/18/1992	EP0474846A1 Polypeptides with a dopaminergic receptor activity, nucleic acids coding for these polypeptides and use of these polypeptides to screen active substances on these polypeptides.
03/18/1992	EP0474783A1 Vpt protein, vectors expressing this protein, cell products and assay methods
03/18/1992	EP0474646A1 Bordetella vaccines
03/18/1992	EP0420894A4 Large scale method for purification of high purity heparinase
03/18/1992	EP0303625B1 Polypeptide competitor for immunoglobulin e
03/18/1992	EP0216786B1 Purification, production and use of tumor necrosis factors
03/18/1992	CN1059561A Prepn. of two pairs of attractants for detecting human body's giant cell virus dna
03/18/1992	CA2091905A1 Fungicidally active compounds
03/17/1992	US5096884 Glidobactin pf-1 peptide antibiotics
03/17/1992	US5096816 Increasing production of terminally sialylated secreted monoclonal antibody in an ammonia cell culture by growing the cells at a pH of 7.2-7.4, gradually decreasing pH to 6.7-7.05 and maintaining during production phase, harvesting
03/17/1992	US5096815 Generation and selection of novel dna-binding proteins and polypeptides
03/17/1992	CA1297635C Protein purification
03/17/1992	CA1297437C Process for the preparation of protease inhibitors
03/17/1992	CA1297436C Eucaryotic expression system
03/17/1992	CA1297435C Messenger rna stabilization in animal cells
03/17/1992	CA1297434C Method of producing peptides, recombinant plasmid for use in the same and animal cells transformed with the same
03/15/1992	WO1992005198A1 EXPRESSION OF MACROPHAGE INDUCIBLE PROTEINS (MIPs) IN YEAST CELLS
03/15/1992	CA2091266A1 Expression of macrophage inducible proteins (mips) in yeast cells
03/15/1992	CA2038202A1 Dna and use thereof
03/13/1992	WO1992004367A1 Separation of proteins and dyes
03/12/1992	WO1992004381A1 Novel antibodies for treatment and prevention of infection in animals and man
03/12/1992	CA2091335A1 Antibodies for treatment and prevention of infection in animals and man
03/12/1992	CA2051047A1 Glycoprotein sialylation by gene manipulation
03/12/1992	CA2051044A1 Cytostatic agent
03/12/1992	CA2049214A1 Use of bacillus thuringiensis microbes for controlling the lesser mealworm, alphitobius diaperinus
03/11/1992	WO1992004456A1 Recombinant acc synthase
03/11/1992	EP0474506A1 Antimicrobial peptides
03/11/1992	EP0474416A2 Antigenic material, antibodies raised thereto, hybridomas for producing antibodies, and immunoassays incorporating such antibodies
03/11/1992	EP0474313A2 Nucleotide sequence coding for an outer membrane protein from Neisseria meningitidis and use of said protein in vaccine preparations
03/11/1992	EP0474212A2 Enzymatic process for conversion of preproinsulin to insulin
03/11/1992	EP0473961A2 Immunoassay reagents and method for determining cyclosporine
03/11/1992	EP0473725A1 Composition and method to detect sensitivity to alpha interferon therapy
03/11/1992	EP0473721A1 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
03/11/1992	EP0473716A1 Dominant negative members of the steroid/thyroid superfamily of receptors
03/11/1992	EP0473651A1 Monoclonal antibodies which recognise malignant cells from bladder carcinomas
03/11/1992	EP0435877A4 Polynucleotides that encode the human proteoglycan peptide core of the effector cells of the immune response
03/11/1992	EP0431042A4 A method of preparing an active human neutrophil chemotactic factor polypeptide
03/11/1992	EP0205506B1 A method of transforming fungi with a vector
03/11/1992	EP0200757B1 Promotion of wound healing with human epidermal growth factor prepared from recombinant dna
03/10/1992	WO1992004382A1 Solubilization of proteins in active forms
03/10/1992	US5095139 Fungicides
03/10/1992	US5095097 Diagnostics
03/10/1992	US5095096 Fused protein comprising lymphotoxin
03/10/1992	US5095094 A43 kDa antigenic protein of Bordetella recognized by polyclonal antibodies to adenylate cyclase but devoid of calmodulin-activatable adenylate cyclase activity
03/10/1992	US5094952 Hydrolytic enzyme
03/10/1992	US5094951 Genetic engineering
03/10/1992	US5094949 Side effect reduction
03/10/1992	US5094946 Enzymatic processing of materials containing chromium and protein
03/10/1992	CA1297055C Method for selectively increasing the ratio of single major components ofantibiotic a/40926 complex
03/10/1992	CA1297051C Expression of the cloned lysostaphin gene
03/10/1992	CA1297050C Expression systems for over production of desired proteins
03/10/1992	CA1297049C Monoclonal antibodies against activated ras proteins with amino acid mutations at position 13 of the protein
03/05/1992	WO1992004463A1 Cd58-specific monoclonal antibodies and their use
03/05/1992	WO1992003570A1 Monoclonal antibodies capable of binding to human and rat insulin
03/05/1992	WO1992003569A1 Protein polyligands joined to a stable protein core
03/05/1992	WO1992003568A1 Sugar modified oligonucleotides that detect and modulate gene expression
03/05/1992	WO1992003552A1 P. falciparum-infected red corpuscles and immunogenic compositions containing same
03/05/1992	WO1992003550A1 Ryegrass pollen allergen
03/05/1992	WO1992003548A1 Human zona pellucida protein zp3
03/05/1992	WO1992003539A1 Virus resistance in plants
03/05/1992	WO1992003537A1 Self-assembling replication defective hybrid virus particles
03/05/1992	WO1992003535A1 Recombinant bpi proteins, uses of bpi proteins, and methods of preparing same
03/05/1992	WO1992003477A1 Biologically active compound, a process for the preparation thereof and use of the same
03/05/1992	WO1992003467A1 Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis
03/05/1992	WO1992003457A1 Entamoeba histolytica immunodominant surface antigens
03/05/1992	WO1991015516A3 Hepatitis c virus epitopes
03/05/1992	CA2090105A1 Protein polyligands joined to a stable protein core
03/05/1992	CA2089497A1 Self-assembling replication defective hybrid virus particles
03/05/1992	CA2081770A1 A cd58-specific monoclonal antibody and the use thereof
03/04/1992	EP0473210A2 Recombinant Marek's disease virus
03/04/1992	EP0473128A2 Monoclonal antibody specifically reactive with human perforin
03/04/1992	EP0473111A2 Recombinant mite allergen
03/04/1992	EP0473080A2 Chondromodulin-I protein
03/04/1992	EP0472987A1 Antimicrobial peptides active against plant pathogens, their use and screening methods pertaining thereto
03/04/1992	EP0472662A1 Antifreeze polypeptides
03/04/1992	EP0472659A1 T-lymphotropic retrovirus monoclonal antibodies
03/04/1992	EP0472658A1 Fusion proteins having an in vivo post-translational modification site and methods of manufacture and purification
03/04/1992	EP0472638A1 Method for isolating receptors having a preselected specificity
03/04/1992	EP0472599A1 Methods and systems for determining the presence of a pneumocystis carinii antigen in blood
03/04/1992	EP0472579A1 Ribosomal frameshift signals and uses
03/04/1992	EP0328542B1 Antiparathyroid antibody preparation
03/03/1992	US5093261 Monoclonal antibodies
03/03/1992	US5093257 Hybrid prokaryotic polypeptides produced by in vivo homologous recombination
03/03/1992	US5093243 Process for the separation and recovery of nosiheptide
03/03/1992	US5093242 Methods of generating desired amino-terminal residues in proteins
03/03/1992	US5093241 C-terminal cat fusion protein and process of preparation by recombinant dna
03/03/1992	US5093115 Method of preparing activated killer monocytes for treating colorectal cancer
03/03/1992	CA1296669C Substance gif-2 and process for production of the same
03/03/1992	CA1296662C Hybridoma cell lines and their monoclonal antibodies to human pluripotent granulocyte colony stimulating factor
03/03/1992	CA1296661C Monoclonal antibodies specific for synthetic glycosphingolipids
03/03/1992	CA1296660C Monoclonal antibody against a ras oncogene p21 related dodecapeptide
03/01/1992	WO1992005760A1 Method and compositions for diagnosing and treating chronic fatigue immunodysfunction syndrome
03/01/1992	WO1992004459A1 Macrophage activating factor from vitamin d binding protein
03/01/1992	WO1992004455A1 Multidomain hematopoiesis stimulators

1 ... 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 ... 1125